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Allergies are common health problems throughout the world that 
contribute significantly to patient populations in both primary 
care and specialist practices in South Africa (SA). Allergy testing 
in conjunction with a good patient history remains the cornerstone 
of allergy diagnosis and appropriate allergy management. The 
identification of allergic sensitisation patterns in SA, as well as 
regional variations in these patterns, should guide the ordering 
of appropriate tests in symptomatic patients and contribute to 
guidelines for appropriate allergy diagnosis.[1]
Allergy testing may be expensive if large allergen panels are 
ordered indiscriminately. Therefore, it is essential to identify the 
most appropriate allergens to be tested, which will not only benefit 
the patient financially, but also lead to appropriate diagnosis with the 
resultant health benefits.
Objectives
To collect and analyse data on national and regional allergen 
sensitisation patterns in the private healthcare sector of SA. This 
analysis could indicate whether the current national allergy testing 
recommendations are relevant, whether additional allergens may 
need to be considered for future testing protocols and whether there 
is a distinct regional difference in allergen sensitisation patterns.
Methods
Retrospective data on allergy testing performed from 1 January 2016 
to 31 December 2017 at AMPATH, a national private pathology 
provider in SA, were collected anonymously from patient databases. 
The site where the SPT was performed or where the patient’s blood 
specimen for allergy testing was collected was used to categorise 
patients demographically. Patient data originating from the nine 
provinces of SA were collected. The Northern Cape data were 
excluded from regional allergen analysis, as the volumes of allergy 
tests ordered were not sufficient to identify statistically significant 
regional allergens. Skin-prick testing (SPT) was not available in the 
Northern Cape or the Free State, therefore no regional SPT data were 
available for these regions. 
Data were collected on SPT (Immunotek, Spain) and allergen-
specific IgE testing (ImmunoCAP; Thermo Fisher Scientific Inc., 
Sweden). Special attention was given to regional allergen sensitisation 
patterns and differences between SPT and allergen-specific IgE 
sensitisation results. Data were collected on allergens frequently 
requested as per the South African Allergic Rhinitis Working 
Group (SAARWG)/Allergy Society of South Africa (ALLSA) 
protocol for IgE-mediated allergy, namely Bermuda grass, Rye 
grass, Dermatophagoides pteronyssinus,  Blomia tropicalis, Alternaria 
alternata, Aspergillus fumigatus, Cladosporium herbarum, cat and 
dog, as well as the more frequently requested regional allergy 
tests and cross-reactive allergen component tests. Allergen-specific 
IgE was reported as a value between 0.1 and 100 kUA/L, with 
allergen sensitisation defined as the presence of allergen-specific IgE 
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>0.35 kUA/L. A skin test with a mean wheal diameter at least 
3 mm greater than the negative saline control was considered to 
be positive and an indicator of allergen sensitisation.[2]
For this descriptive study data were presented in tabular 
form, initially grouping individual allergen positivity nationally, 
followed by individual allergen positivity per geographic region. 
A 95% confidence interval was used and data were analysed 
using STATA version 14 (StataCorp., USA). 
Results
A total of 45  032 patients were tested for a suspected inhalant 
allergy with a Phadiatop screening test (ImmunoCAP) and a total 
of 6 775 patients were tested for an inhalant allergy by SPT.
Of the patients who were tested by the Phadiatop allergy 
screening test, 20  696 (46%) returned positive results for an 
allergic sensitisation. However, only 9 395 (45%) of these patients 
received additional testing, according to the SAARWG/ALLSA 
recommendations, to identify the causative inhalant allergen.
Data were assessed to determine the most prevalent 
sensitisation patterns overall for the individual allergen-specific 
IgE allergens tested on patients with positive Phadiatop inhalant 
screens (Table 1). A regional breakdown of the sensitisation 
patterns for individual IgE allergens tested on patients with 
positive Phadiatop inhalant screens was performed and reported 
as a point prevalence (Table 2). 
On analysis of SPT data, it was found that 3 980 of the 6 775 
SPTs performed (59%) yielded one or more positive results. A 
regional breakdown was performed of the sensitisation patterns 
for individual IgE allergens on SPT and reported as a point 
prevalence (Table 3).
As the house dust mite is one of the most important allergens 
in SA,[3] data were further analysed to investigate potential 
cross-reactivity between D. pteronyssinus and B. tropicalis 
on specific IgE testing and SPT. Regional sensitisation to 
D. pteronyssinus IgE (Table 4) or house dust mite (HDM) mix 
SPT (Table 5) was compared with B. tropicalis sensitisation in 
patients on whom both allergens were tested simultaneously.
As grass pollen is a major allergen in SA and maize pollen, 
which is only included in SPT profiles from four SA provinces, 
has demonstrated significant patient sensitisation, further 
analysis of SPT data for potential cross-reactivity between 
these two allergens was performed.[3] Regional sensitisation to 
Bermuda grass pollen and maize pollen on SPT was compared 
in patients on whom both allergens were tested simultaneously 
(Table 6).
Previous SA data have shown an increase in sensitisation 
rates to foods of plant origin in regions with the highest pollen 
Table 1. Positivity rate of patients testing positive on 
a Phadiatop inhalant screen (N=9 395) for individual 
inhalant IgE allergens
Allergen n (%)
D. pteronyssinus 5 269 (56)
Bermuda grass 4 958 (53)
Rye grass 4 653 (50)
A. alternata 3 335 (35)
B. tropicalis 3 101 (33)
Dog 2 719 (29)
Cat 2 217 (24)
A. fumigatus 2 214 (24)
C. herbarum 1 812 (19) Ta
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sensitisation rates.[4] A potential explanation may be cross-reactivity 
caused by sensitisation to food-pollen cross-reactive components, 
e.g. lipid transfer proteins (LTP), Profilin, PR-10 and cross-reactive 
carbohydrate determinants (CCD).
Food allergen-specific IgE data were analysed; 16 202 of positive 
IgE food allergen screens (Fx5 multitest and ImmunoCAP) were 
broken down into individual food allergen components. A total of 
4  072 (25%) of the positive screens on which individual allergen-
specific IgE tests (ImmunoCAP) were performed, demonstrated 
combined sensitisation to wheat, soy and peanut. Only 22 (0.5%) 
patients with triple sensitisation underwent additional allergen-
specific IgE component testing to the four most common food-pollen 
cross-reactive components, namely LTP, Profilin, PR-10 and CCD, 
and 90% of these patients were sensitised to one of the four common 
cross-reactive components, with the most frequent sensitisation 
being to CCD and then to LTP.
Discussion
ImmunoCAP IgE sensitisation data revealed that house dust mite 
sensitisation (D. pteronyssinus IgE on ImmunoCAP) was the most 
common sensitiser overall, followed by grass pollen (Bermuda and 
rye grass) and then by the mould A. alternata. However, overall 
A. alternata sensitisation patterns may be biased by the inclusion of 
the highest percentage of patients from Gauteng, where this fungus 
is a common allergen. The lowest overall sensitisation for one of 
the nine recommended ImmunoCAP IgE allergens to be tested in 
the ALLSA/SAARWG panel was for the fungus C. herbarum, with a 
positivity rate of only 8% in KwaZulu-Natal. Generally, an allergen 
is seen to contribute significantly to allergy in a community if 
sensitisation levels rise above 2%.[5] 
A regional breakdown of allergen-specific IgE sensitisation to the 
individual allergens in the ALLSA/SAARWG panel demonstrated that 
two of the top three allergens in all provinces were D. pteronyssinus 
and Bermuda grass. Gauteng and North West provinces demonstrated 
similar sensitisation patterns, and KwaZulu-Natal and Eastern 
Cape provinces demonstrated similar sensitisation patterns. The 
most notable regional differences were lower sensitisation levels to 
B. tropicalis in Gauteng, the Free State and North West provinces and 
very high levels of sensitisation in KwaZulu-Natal and the Eastern 
Cape, with the Western Cape lagging slightly behind. 
A regional breakdown of SPT data also confirmed house dust mite 
(D. pteronyssinus and/or D. farinae) and Bermuda grass to be very 
prominent allergens. It is interesting to observe that maize pollen was 
amongst the top five sensitising allergens in Gauteng, Mpumalanga 
and North West provinces. Also of note is that cockroach was among 
Table 3. Ranking of regional sensitisation for individual allergens based on SPT 
Ranking position
Provincial regions of South Africa
Gauteng North West Mpumalanga KwaZulu-Natal Eastern Cape Western Cape
1
Maize pollen Bermuda grass HDM mix† HDM mix† HDM mix† HDM mix†
35% 29% 30% 41% 48% 44%
2
Bermuda grass House dust mite† Bermuda grass B. tropicalis B. tropicalis Grass mix
31% 27% 24% 32% 29% 34%
3
HDM mix† Maize pollen B. tropicalis Cockroach Grass mix* Bermuda grass
30% 25% 24% 17% 24% 30%
4
Grass mix* Grass mix* A. alternaria Bermuda grass Bermuda grass B. tropicalis
26% 20% 23% 15% 24% 30%
5
Cat B. tropicalis Maize pollen Mould mix‡ Cockroach Cat
21% 14% 19% 13% 19% 25%
*Grass mix consists of Holcus lanatus, Dactylis glomerata, Lolium perenne, Phleum pratense, Poa pratensis and Festuca pratensis.
†HDM mix consisted of Dermatophagoides pteronyssinus and Dermatophagoides farinae.
‡Mould mix consisted of Alternaria alternata, Cladosporium herbarum, Aspergillus fumigatus and Penicillium notatum.
Table 4. Regional breakdown of patients on whom 
D. pteronyssinus and B. tropicalis were requested for 
simultaneous IgE testing and where dual sensitisation was 
detected 
Provincial region
Test requests,  
n
Dual sensitisation, 
n (%)
KwaZulu-Natal 1 789 1 067 (60)
Western Cape 1 029 433 (42)
Eastern Cape 611 229 (37)
Limpopo 247 73 (30)
Mpumalanga 226 62 (27)
North West 636 124 (19)
Gauteng 6 075 1 044 (17)
Free State 94 11 (12)
Table 5. Regional breakdown of patients on whom House 
dust mite mix and B. tropicalis were tested simultaneously by 
SPT and where dual sensitisation was detected
Provincial region
Test requests,  
n
Dual sensitisation, 
n (%)
Eastern Cape 460 124 (27)
Western Cape 329 87 (26)
Kwazulu-Natal 244 48 (20)
Mpumalanga 70 12 (17)
Gauteng 2 788 401 (14)
Limpopo 33 4 (12)
North West 98 9 (9)
Table 6. Regional breakdown of patients on whom Bermuda 
grass pollen and maize pollen were tested simultaneously by 
SPT and where dual sensitisation was detected 
Provincial region
Test requests,  
n
Dual sensitisation, 
n (%)
Gauteng 1 948 557 (29)
North West 92 19 (21)
Mpumalanga 62 11 (18)
Limpopo 33 4 (12)
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the top five sensitising allergens in KwaZulu-Natal and Eastern 
Cape provinces. This is a concerning finding, as maize pollen and 
cockroach are not included in the current ALLSA/SAARWG profile 
for allergen-specific IgE inhalant allergen testing. 
There are few data available on the sensitisation and potential cross-
reactivity between B. tropicalis and D. pteronyssinus in the SA setting. 
A previous study with limited numbers of private patients in KwaZulu-
Natal and Johannesburg, Gauteng, showed a 52% sensitisation rate to 
B. tropicalis in KwaZulu-Natal on SPT (Stellargenes, France) and a 
sensitisation rate of 3% in Johannes burg.[6]
As a secondary aim potential cross-reactivity between D. pteron­
yssinus and B. tropicalis was investigated. It is important to identify 
patients sensitised to B. tropicalis, as these patients only respond 
to B. tropicalis-specific immunotherapy vaccines.[7] Regional data 
of patients co-sensitised to D. pteronyssinus and B. tropicalis were 
analysed on both ImmunoCAP IgE (Thermo Fisher Scientific, 
Sweden) and SPT. The co-sensitisation rates were higher in coastal 
areas (KwaZulu-Natal, Eastern Cape and Western Cape), suggesting 
true sensitisation in these regions. These areas have suitable climates 
for the mite, B. tropicalis, to thrive in.[6,7] However, there was not 
enough information available to determine true levels of cross-
reactivity between B. tropicalis and D. pteronyssinus, as B. tropicalis-
specific IgE allergen components are currently not available on 
ImmunoCAP. The sensitisation levels to B. tropicalis detected in 
Gauteng were higher than reported previously and may be attributed 
to the different tests and test manufacturers, which may influence 
test sensitivity and specificity, as well as differences in study patient 
populations.
There are currently no data available on the true sensitisation 
levels to maize pollen in SA. Cross-reactivity between maize pollen 
and Bermuda grass pollen has been suggested, as these two plant 
species are more closely related than maize pollen and rye grass. [8,9] 
Maize pollen testing is not included in the top nine allergens 
recommended in the SAARWG/ALLSA diagnostic protocol for 
inhalant allergen testing. However, it is included in local SPT 
protocols in four SA provinces. These SPT data revealed that 29% 
of patients in Gauteng who were sensitised to Bermuda grass, were 
also co-sensitised to maize pollen. As the overall sensitisation rate 
in Gauteng on SPT was 31% to Bermuda grass and 35% to maize 
pollen, these results indicate that some patients are primarily 
sensitised to maize pollen and that it may be a significant allergen 
in the Gauteng region. There is a great need for a maize-specific 
IgE allergen component to identify patients primarily sensitised to 
maize pollen. 
Allergen data were examined to determine potential food-pollen 
cross-reactive component sensitisation. Previous SA data have shown 
an increase in sensitisation rates to foods of plant origin in regions 
with the highest pollen sensitisation rates.[4] From the authors’ 
experience, patients with triple sensitisation to wheat, peanut and 
soy are often sensitised to pollen cross-reactive components. Only 
a minority of these patients have clinical symptoms when ingesting 
these plant foods.[10-12] If symptomatic, the most frequent symptoms 
are those of oral allergy syndrome, but urticaria and even anaphylaxis 
have been described in patients sensitised to LTP.[13] It is important 
to diagnose the relevant cross-reactive component, as it will have 
clinical implications regarding dietary and allergen avoidance advice 
to patients. Identification of patients with only CCD sensitisation will 
also avoid unnecessary dietary exclusion of wheat, peanut, soy and 
other plant-based foods from the patient’s diet.
It was notable that 25% of all patients with a positive food allergen-
specific IgE screen demonstrated positive sensitisation to wheat, 
soy and peanut in combination. These sensitisation levels are much 
higher than the expected prevalence of food allergy.[14] As these plant 
foods are not phylogenetically closely related, the likelihood that 
these patients could be sensitised to unique allergens in each of these 
diverse plant allergens is extremely low. 
Only 22 patients (0.5%) had additional ImmunoCAP allergen-
specific IgE component testing for the four most common food-
pollen cross-reactive components, namely LTP, Profilin, PR-10 
and CCD IgE. Some patients had ImmunoCAP ISAC component 
microarray tests performed. However, the data are not included in 
this analysis. Although these numbers were small, it was notable that 
90% of triple sensitised patients were positive to one of these four 
food-pollen cross-reactive components on ImmunoCAP IgE, most 
frequently CCD followed by LTP. The distinction between these two 
sensitisation patterns is relevant, as CCD sensitisation does not cause 
symptoms after allergen exposure, while LTP sensitisation may cause 
a severe systemic allergy upon allergen exposure.[13]
Study limitations
One of the main disadvantages when analysing anonymous 
retrospective data is the lack of access to patient history and 
clinical records. Therefore, the authors could only report on allergen 
sensitisation and not clinically relevant allergy. Gauteng was the most 
represented province, therefore the national sensitisation data may 
be biased. Another limitation is that data were only available for 
patients with access to private healthcare, therefore the data may not 
be representative of patients in the public sector. SPT data couldn’t be 
compared for all allergens between all regions, as some SPT profiles 
vary regionally and SPT is also restricted to larger towns and cities 
in SA. 
Conclusions
Inhalant allergy testing positivity rates were 46% for the Phadiatop 
atopy screen and 59% for inhalant SPT panels, indicating appropriate 
use for the diagnosis of inhalant allergies. This is comparable with 
international data.[5,15] However, only 45% of patients with a positive 
Phadiatop atopy screen received additional testing for specific 
inhalant allergens, according to SAARWG/ALLSA recommendations, 
to identify the causative inhalant allergen. This is sub-optimal, as 
no therapeutic recommendations can be made regarding allergen 
avoidance or immunotherapy if additional testing is not performed.
Of the nine recommended inhalant allergens tested on allergen-
specific IgE tests, the lowest sensitisation level was 8% to C. herbarum 
in KwaZulu-Natal, which is significantly higher than recommended 
sensitisation levels for relevant allergens in a community.[5] The 
current allergen selection appears to be appropriate if applying this 
criterion. However, there is some regional variation in sensitisation 
patterns, particularly to B. tropicalis, cockroach and maize pollen, 
which is not reflected in these recommendations. International 
studies have indicated that the minimum battery of inhalant allergy 
tests needed to identify all sensitised patients may vary. Up to 
13  allergens are required to identify sensitised patients in some 
European countries.[5] It is of concern that there may be additional 
allergens, as were identified in this study, that may contribute 
significantly to patients’ allergy symptoms and which are not included 
in the current testing protocols. 
There was a high percentage (25%) of patients who were 
co-sensitised to wheat, soy and peanut, suggesting food-pollen cross-
reactivity rather than primary food allergen sensitisation. However, 
the uptake of component testing to resolve potential cross-reactivity is 
very low, despite result comments and recommendations suggesting 
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their use. Consideration should be given to the implementation of 
testing algorithms and protocols for patients with suspected food-
pollen cross-reactivity, as the unnecessary dietary exclusion of these 
allergens has a significant social, nutritional and financial impact on 
patients and their families.
The results of the present study confirm the relevance of the current 
inhalant allergens tested in SA testing protocols, identify new potential 
allergens and regional sensitisation patterns. Awareness is also raised 
about a significant level (25%) of potential food-pollen cross-reactivity 
which may impact patient management. These findings may aid the 
recommendations for the most appropriate and cost-effective approach 
to allergy testing in symptomatic patients in SA.
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